There have been 50 recent insider transactions recorded for REGENXBIO Inc. (RGNX), including 21 buys and 27 sells. Total insider buying was valued at $11.61M and total insider selling at $4.94M.
Notable insiders with recent activity include Pakola Steve, Christmas Patrick J., Mills Kenneth T.. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — RGNX
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-10 |
Pakola Steve |
Chief Medical Officer |
Informative Sell |
5,124 |
$10.35 |
$53.03K |
247,926 |
| 2026-02-01 |
Christmas Patrick J. |
Chief Strategy & Legal Officer |
Tax Withholding of RSU |
4,700 |
$11.16 |
$52.45K |
210,667 |
| 2026-02-01 |
Pakola Steve |
Chief Medical Officer |
Tax Withholding of RSU |
5,267 |
$11.16 |
$58.78K |
253,050 |
| 2026-01-27 |
Mills Kenneth T. |
Director |
Option Exercise (Sell) |
225,000 |
$13.09 |
$2.95M |
225,000 |
| 2026-01-06 |
Simpson Curran |
Chief Executive Officer |
RSU Award |
233,651 |
$14.18 |
$3.31M |
233,651 |
| 2026-01-06 |
Christmas Patrick J. |
Chief Strategy & Legal Officer |
RSU Award |
39,650 |
$14.18 |
$562.24K |
39,650 |
| 2026-01-06 |
Pakola Steve |
Chief Medical Officer |
RSU Award |
35,402 |
$14.18 |
$502K |
35,402 |
| 2026-01-06 |
Chan Mitchell |
Chief Financial Officer |
RSU Award |
39,650 |
$14.18 |
$562.24K |
39,650 |
| 2026-01-06 |
Malzahn Craig |
Chief Technology Officer |
RSU Award |
35,402 |
$14.18 |
$502K |
35,402 |
| 2026-01-02 |
Simpson Curran |
Chief Executive Officer |
Tax Withholding of RSU |
18,559 |
$14.40 |
$267.25K |
197,603 |
| 2026-01-02 |
Christmas Patrick J. |
Chief Strategy & Legal Officer |
Tax Withholding of RSU |
9,793 |
$14.40 |
$141.02K |
141,618 |
| 2026-01-02 |
Pakola Steve |
Chief Medical Officer |
Tax Withholding of RSU |
18,247 |
$14.40 |
$262.76K |
192,470 |
| 2026-01-02 |
Malzahn Craig |
Chief Technology Officer |
Tax Withholding of RSU |
1,238 |
$14.40 |
$17.83K |
16,347 |
| 2025-10-09 |
Simpson Curran |
Chief Executive Officer |
Informative Sell |
20,811 |
$12.62 |
$262.63K |
216,162 |
| 2025-09-29 |
Simpson Curran |
Chief Executive Officer |
Informative Sell |
7,624 |
$10.03 |
$76.47K |
236,973 |
| 2025-09-10 |
Simpson Curran |
Chief Executive Officer |
Informative Sell |
7,734 |
$10.02 |
$77.49K |
244,597 |
| 2025-09-01 |
Chan Mitchell |
Chief Financial Officer |
Tax Withholding of RSU |
4,901 |
$8.93 |
$43.77K |
53,968 |
| 2025-09-01 |
Malzahn Craig |
Chief Technology Officer |
Tax Withholding of RSU |
234 |
$8.93 |
$2.09K |
17,585 |
| 2025-08-01 |
Christmas Patrick J. |
Chief Strategy & Legal Officer |
Tax Withholding of RSU |
4,699 |
$8.19 |
$38.48K |
151,411 |
| 2025-07-01 |
Simpson Curran |
Chief Executive Officer |
Tax Withholding of RSU |
4,701 |
$8.23 |
$38.69K |
252,331 |
| 2025-05-30 |
Migausky George V |
Director |
RSU Award |
7,768 |
- |
- |
19,054 |
| 2025-05-30 |
Karabelas Argeris N |
Director |
RSU Award |
7,768 |
- |
- |
19,054 |
| 2025-05-30 |
Stump David C |
Director |
RSU Award |
7,768 |
- |
- |
19,054 |
| 2025-05-30 |
Tasse Daniel |
Director |
RSU Award |
7,768 |
- |
- |
19,054 |
| 2025-05-30 |
Mills Kenneth T. |
Director |
RSU Award |
39,815 |
$8.85 |
$352.36K |
39,815 |
| 2025-05-30 |
Fox Allan M. |
Director |
RSU Award |
7,768 |
- |
- |
19,054 |
| 2025-05-30 |
Glucksmann Alexandra |
Director |
RSU Award |
7,768 |
- |
- |
19,054 |
| 2025-05-30 |
Zachary Jennifer |
Director |
RSU Award |
7,768 |
- |
- |
22,064 |
| 2025-05-30 |
Bennett Jean |
Director |
RSU Award |
7,768 |
- |
- |
19,054 |
| 2025-05-12 |
Mills Kenneth T. |
Director |
Option Exercise (Sell) |
20,602 |
$3.76 |
$77.46K |
- |
| 2025-03-27 |
Mills Kenneth T. |
Director |
Option Exercise (Sell) |
30,752 |
$3.76 |
$115.63K |
20,602 |
| 2025-03-13 |
Malzahn Craig |
Chief Technology Officer |
Unknown |
33,150 |
$7.86 |
$260.56K |
- |
| 2025-02-01 |
Christmas Patrick J. |
Chief Legal Officer |
Tax Withholding of RSU |
4,700 |
$8.07 |
$37.93K |
156,110 |
| 2025-02-01 |
Pakola Steve |
Chief Medical Officer |
Tax Withholding of RSU |
5,263 |
$8.07 |
$42.47K |
210,717 |
| 2025-02-01 |
Danos Olivier |
Chief Scientific Officer |
Tax Withholding of RSU |
5,452 |
$8.07 |
$44K |
226,348 |
| 2025-01-02 |
Simpson Curran |
Chief Executive Officer |
Tax Withholding of RSU |
11,917 |
$7.73 |
$92.12K |
158,120 |
| 2025-01-02 |
Christmas Patrick J. |
Chief Legal Officer |
Tax Withholding of RSU |
11,395 |
$7.73 |
$88.08K |
160,810 |
| 2025-01-02 |
Pakola Steve |
Chief Medical Officer |
RSU Award |
103,698 |
$7.86 |
$815.07K |
103,698 |
| 2025-01-02 |
Danos Olivier |
Chief Scientific Officer |
RSU Award |
95,721 |
$7.86 |
$752.37K |
95,721 |
| 2025-01-02 |
Chan Mitchell |
Chief Financial Officer |
RSU Award |
62,547 |
$7.86 |
$491.62K |
62,547 |
| 2025-01-02 |
Simpson Curran |
Chief Executive Officer |
RSU Award |
478,606 |
$7.86 |
$3.76M |
478,606 |
| 2024-10-01 |
Karabelas Argeris N |
Director |
Option Exercise (Sell) |
10,000 |
$3.76 |
$37.6K |
- |
| 2024-09-16 |
Chan Mitchell |
Officer |
Unknown |
- |
- |
- |
- |
| 2024-09-16 |
Chan Mitchell |
Chief Financial Officer |
RSU Award |
58,869 |
- |
- |
58,869 |
| 2024-09-03 |
Karabelas Argeris N |
Director |
Option Exercise (Sell) |
10,000 |
$3.76 |
$37.6K |
10,000 |
| 2024-08-08 |
Mills Kenneth T. |
Director |
Option Exercise (Sell) |
36,316 |
$0.85 |
$30.87K |
- |
| 2024-08-01 |
Karabelas Argeris N |
Director |
Option Exercise (Sell) |
100 |
$12.74 |
$1.27K |
1,400 |
| 2024-08-01 |
Simpson Curran |
Chief Executive Officer |
Informative Sell |
100 |
$15.00 |
$1.5K |
170,037 |
| 2024-08-01 |
Christmas Patrick J. |
Chief Legal Officer |
RSU Award |
56,446 |
- |
- |
172,205 |
| 2024-08-01 |
Pakola Steve |
Chief Medical Officer |
RSU Award |
58,386 |
- |
- |
165,578 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
